(Phys.org)—New insights by WAIMR researchers into how a tiny microRNA molecule may suppress prostate tumours have been published internationally, in the Journal of Biological Chemistry.
A new study has concluded that sports fans love to root for a hero and against a villain, but if the game is exciting, they'll enjoy it no matter who wins.
A team of chemists at USC has developed a way to transform a hitherto useless ozone-destroying greenhouse gas that is the byproduct of Teflon manufacture and transform it into reagents for producing pharmaceuticals.
Molecular chaperones have emerged as exciting new potential drug targets, because scientists want to learn how to stop cancer cells, for example, from using chaperones to enable their uncontrolled growth. Now a team of biochemists ...
(Phys.org)—Virginia Tech researchers have discovered a potential way to create a new kind of anticoagulant drug commonly called a blood thinner.
Scientists have discovered an enzyme used in nature to make powerful chemicals from catnip to a cancer drug, vinblastine. The discovery opens up the prospect of producing these chemicals cheaply and efficiently.
A medical researcher with the University of Alberta and his team just published their findings about their work on developing 'homing beacon drugs' that kill only cancer cells, not healthy ones, thanks to nanotechnology.
(Phys.org)—In a world-first, researchers from the Australian Centre for Nanomedicine at the University of New South Wales (UNSW) in Sydney have developed a nanoparticle that could improve the effectiveness of chemotherapy ...
Certain mutated cells keep trying to replicate their DNA—with disastrous results—even after medications rob them of the raw materials to do so, according to new research from USC.
A group of researchers at the University of California, Berkeley have for the first time described the structure of the active site core of topoisomerase II alpha, an important target for anti-cancer drugs.